Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 3Infections 3Wilms Tumor 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Testicular Neoplasms 1Sezary Syndrome 1Sarcoma 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neutropenia 1Neoplasms, Plasma Cell 1

Interventions

Cyclophosphamide 4fludarabine phosphate 3Whole-Body Irradiation 3Melphalan 3Busulfan 3fludarabine 2Thiotepa 2Therapeutics 2Antilymphocyte Serum 2Alemtuzumab 2thymoglobulin 1fosphenytoin 1Voriconazole 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Injections 1Influenza Vaccines 1Honey 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunologic Deficiency Syndromes × Voriconazole × Lymphoid × Clear all
NCT00015665 2008-03-04

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
40 enrolled
Lymphoid

Immunologic Deficiency Syndromes, Infections, Lymphoma, Follicular, Mycoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡